Cantitate/Preț
Produs

Prevention of Bone Metastases: Recent Results in Cancer Research, cartea 192

Editat de Markus Joerger, Michael Gnant
en Limba Engleză Hardback – 5 ian 2012
Bone metastases continue to be a major cause of morbidity in cancer patients, but improved understanding of the biology of bone metastases has led to the identification of drugs that are of potential value in not only their treatment but also their prevention. This book, written by recognized experts in the field, provides a detailed overview of current knowledge on this subject. One important focus of the book is the efficacy of bisphosphonates in preventing bone metastases in patients with breast, lung, and prostate cancer and disease progression in cases of multiple myeloma. The combined use of bisphosphonates and cytostatics is also discussed, with a report on first clinical data. Further topics addressed include the significance of the bone microenvironment, special issues in the elderly patient, the use of bone turnover markers, and initial findings obtained with denosumab.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 76218 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 22 feb 2014 76218 lei  6-8 săpt.
Hardback (1) 107440 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 5 ian 2012 107440 lei  6-8 săpt.

Din seria Recent Results in Cancer Research

Preț: 107440 lei

Preț vechi: 113094 lei
-5% Nou

Puncte Express: 1612

Preț estimativ în valută:
20595 21616$ 16986£

Carte tipărită la comandă

Livrare economică 23 ianuarie-06 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642218910
ISBN-10: 3642218911
Pagini: 244
Ilustrații: X, 234 p.
Dimensiuni: 155 x 235 x 19 mm
Greutate: 0.48 kg
Ediția:2012
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Recent Results in Cancer Research

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Professional/practitioner

Cuprins

Preclinical models that illuminate the bone metastasis cascade.- The role of bone microenvironment, vitamin D and calcium.- Bisphosphonates: Prevention of bone metastases in breast cancer.- Bisphosphonates: Prevention of bone metastases in lung cancer.- Bisphosphonates: Prevention of bone metastases in prostate cancer.- Bisphosphonates: Prevention of disease progression in patients with multiple myeloma.- Combinations of bisphosphonates and classical anticancer drugs - a preclinical perspective.- Special issues in the elderly patient.- Denosumab: First data and ongoing studies on the prevention of bone metastases.- Diagnostic and prognostic use of bone turnover markers.- Osteolytic and osteoblastic bone metastases: Two extremes of the same spectrum?.

Textul de pe ultima copertă

Bone metastases continue to be a major cause of morbidity in cancer patients, but improved understanding of the biology of bone metastases has led to the identification of drugs that are of potential value in not only their treatment but also their prevention. This book, written by recognized experts in the field, provides a detailed overview of current knowledge on this subject. One important focus of the book is the efficacy of bisphosphonates in preventing bone metastases in patients with breast, lung, and prostate cancer and disease progression in cases of multiple myeloma.  The combined use of bisphosphonates and cytostatics is also discussed, with a report on first clinical data.  Further topics addressed include the significance of the bone microenvironment, special issues in the elderly patient, the use of bone turnover markers, and initial findings obtained with denosumab.

Caracteristici

Overview of current knowledge regarding the prevention of bone metastases in a variety of cancers Detailed analysis of the efficacy of bisphosphonates, including in combination with cytostatics Written by acknowledged experts in the field Includes supplementary material: sn.pub/extras